The FDA approved the first mRNA flu vaccine for use in older adults. Here’s what to know - CNN

Core Impact Points

• The FDA has approved the first mRNA flu vaccine for use in older adults.
• The vaccine is expected to provide better protection against flu strains and reduce hospitalizations.
• The approval of this vaccine is a testament to the rapid progress made in mRNA technology.
• The vaccine is designed to be administered to individuals aged 65 and older.
• The approval of this vaccine is a crucial step towards improving public health, particularly for vulnerable populations.
• The vaccine is expected to play a vital role in reducing the burden on the healthcare system during the flu season.